For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Jeffrey B. Hoag

Jeffrey B. Hoag, MD

Associate Professor

Specialties: Pulmonary Medicine, Critical Care


  • MD - Medical College of Virginia (2001)
  • MS - Virginia Commonwealth University School of Medicine (1996)
  • BS - University of Richmond (1993)

Clinical Background

Dr. Hoag is the director of the Drexel Adult Cystic Fibrosis Center. He has served as director of the progressive care unit and MICU – East at Hahnemann University Hospital, and he is currently the director of critical care for Cancer Treatment Centers of America, Eastern Regional Medical Center in Philadelphia.

Dr. Hoag is active in both cystic fibrosis-specific clinical trials as well as investigator initiated studies. He is a member of the Cystic Fibrosis Foundation's Therapeutics Development Network, and he is a member of the National Resource Center Committee for this network. Recently, he has been selected to be a member of the Chronic Pulmonary Therapies Guidelines Committee for the Cystic Fibrosis Foundation.

Epistaxis Severity Score (ESS) for Hereditary Hemorrhagic Telangiectasia

Affiliated Hospitals: Hahnemann University Hospital; Cancer Treatment Centers of America - Eastern Regional Medical Center

Clinical Services

Cystic fibrosis, Hereditary hemorrhagic telangietasia, Interventional pulmonology, Thoracic oncology, Critical care


  • Pulmonary Medicine - Johns Hopkins University (2007)
  • Critical Care Medicine - Johns Hopkins University (2007)


  • Internal Medicine - Medical College of Virginia (2004)


  • Internal Medicine - Medical College of Virginia (2002)

Dr. Hoag is an associate professor of medicine, and is active in clinical and educational programs for Drexel University College of Medicine, the Internal Medicine Residency program, and the Division of Pulmonary, Critical Care and Sleep Medicine. He serves as co-director of research for the Pulmonary Fellowship program and has mentored many levels of trainees through academic pursuits.

Research Interests

Cystic fibrosis, Hereditary hemorrhagic telangiectasia, Acute lung injury, Interventional pulmonology, Critical care


Dr. Hoag conducts research in several areas including cystic fibrosis, hereditary hemorrhagic telangiectasia, acute lung injury, thoracic oncology, critical care and interventional pulmonology.

He is internationally known for his research focusing on epistaxis related to hereditary hemorrhagic telangiectasia (HHT). Dr. Hoag also has an interest in the effects of malignancy on the respiratory system, critical care outcomes of cancer patients, and interventional pulmonology. He has published 25 articles focusing on cardiovascular and pulmonary physiology in the peer reviewed literature. He has presented research at the American Thoracic Society and American College of Chest Physicians International meetings. At the latter, he was presented with an award by the American Association of Bronchology and Interventional Pulmonology. Moreover, he presented a plenary session at the International Hereditary Hemorrhagic Telangiectasia Meeting in Spain in 2009.

In the News

"Studies from University College Yield New Results on Pneumothorax"
October 4, 2010
Clinical Oncology Week

Selected Publications

"Primary synovial sarcoma of the lung with intra-cardiac extension"
Devarakonda VS, Lembert L, Entwistle J, Chen X, Hoag JB
Respiration; 81:249-252, 2011

"Pulmonary squamous papilloma complicating recurrent tracheal papillomatosis"
Doherty TJ, Lund ME, Chen X, Hoag JB
Curr Respiratory Med Rev; 6:207-209, 2010

"Practice patterns of airway stent maintenance"
Hoag JB, Sherman M, Lund ME
J Bronchol 17:131-5 (2010)

"Spontaneous pneumothorax complicating sarcoma"
Hoag JB, Sherman M, Fasihuddin Q, Lund ME
Chest 138:510-8 (2010)

"An Epistaxis Severity Score for Hereditary Hemorrhagic Telangiectasia"
Hoag JB, Terry P, Mitchell S, Reh D, Merlo C
Laryngoscope 120:838-43 (2010)

"Association of cetuximab with pulmonary adverse events in cancer patients: a comprehensive review"
Hoag JB, Azizi A, Doherty TJ, Lu J, Willis R, Lund ME
J Exp Clin Cancer Res 28:113-120 (2009)

"Pre-deployment modification of a self-expanding metallic stent"
Hoag JB, Juhas W, Morrow K, Standiford S, Lund ME
J Bronchol 15:185-90 (2008)

"Effects of acid-aspiration-induced acute lung injury on kidney function"
Hoag JB, Liu M, Easley RB, Britos Bray M, Kesari P, Hassoun H, Haas M, Tuder R, Rabb H, Simon BA
Am J Physiol Renal Physiol 294:F900-8 (2008)

"An unexpected finding of endobronchial amyloidosis in a patient with mediastinal fibrosis"
Hoag JB, Yung RC
J Bronchology 15:61-3 (2008)

"Recirculation of Inhaled Xenon does not Alter Lung CT Density"
Hoag JB, Fuld M, Brown RH, Simon BA
Acad Radiol 14:81-4 (2007)

"Spontaneous 'baroreflex sequences' occur as deterministic functions of breathing phase"
Rothlisberger BW, Badra LJ, Hoag JB, Cooke WH, Kuusela TA, Tahvanainen KU, Eckberg DL
Clin Physiol Funct Imaging 6:307-13 (2003)

"Respiratory Modulation of Human Autonomic Rhythms"
Badra LJ, Cooke WH, Hoag JB, Crossman AA, Kuusela TA, Tahvanainen KUO, and Eckberg DL
Amer J Physiol Heart Circ Physiol 280:H2674-88 (2001)

"ATP-Sensitive Potassium Channel Mediates Delayed Ischemic Protection by Heat Stress in Rabbit Heart"
Hoag JB, Qian YZ, Nayeem MA, D'Angelo M, and RC Kukreja
Am J Physiol 273:H2458-64 (1997)

In the Media